A B S T R A C T We examined the role ofprostaglandins and thromboxanes as mediators of plasma-dependent increased polymorphonuclear leukocyte adhesiveness induced by Escherichia coli lipopolysaccharide. The cyclo-oxygenase inhibitors-indomethacin and d,l-6-chloro-a-methyl-carbozole-2-acetic acid (R020-5720) -reduced lipopolysaccharide-induced adherence of polymorphonuclear leukocytes by 74 and 62%, respectively. In addition, inhibitors of thromboxane synthetase -imidazole, 9,1 1-azoprosta-5,13-dienoic acid, and 1-benzylimidazole-suppressed the stimulation of adherence by 31, 66, and 83%, respectively. Exogenous prostaglandins El, E2, and F2a did not increase polymorphonuclear leukocyte adherence, nor were they detected in significant quantities in supernates of polymorphonuclear leukocytes exposed to lipopolysaccharide. However, inhibitors of both cyclooxygenase and thromboxane synthetase reduced increases in adherence induced by arachidonic acid (10 ,ug/ml), suggesting that lipopolysaccharidemediated increases in adherence were due to an arachidonic acid product other than prostaglandin E2 or F2a. 8,11,14-Eicosatrienoic acid, a precursor of monoenoic prostaglandins, did not enhance polymorphonuclear leukocyte adhesiveness.
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We next demonstrated lipopolysaccharide-stimulated generation, by polymorphonuclear leukocytes, of a labile, low molecular weight, dialyzable substance capable of enhancing the adherence of unstimulated leukocytes. In Receivedfor publication 27 September 1979 and in revised form 28 April 1980. 406 in immunoreactive thromboxane B2 over basal levels was detected after exposure of leukocytes to lipopolysaccharide. The inhibition of lipopolysaccharide enhancement of adherence by specific rabbit antibodies to thromboxane B2 strongly supported a primary role for thromboxane A2 as the mediator of the observed increases in adherence. Lipopolysaccharide-stimulated purified platelets did not increase leukocyte adherence, whereas thrombin-stimulated platelets did increase adherence.
These studies suggest that lipopolysaccharide stimulates polymorphonuclear leukocytes to produce thromboxane A2, which enhances their adhesiveness to nylon.
by acetylsalicylic acid, an inhibitor of fatty acid cyclo-oxygenase (17) . Our current studies indicate that LPS stimulates PMN to produce TxA2, which increases PMN adhesiveness.
METHODS
Reagents. PGE,, PGE2, PGF2a, and TxB2 (generously provided by Dr. John Pike, Upjohn Co., Kalamazoo, Mich.) were dissolved in Hanks' balanced salt solution (HBSS, KC Biological, Lenexa, Kans.) to appropriate concentrations. Prostacyclin (PGI2, Upjohn Co.) was dissolved in a 9:1 solution of ethanol:Tris buffer, pH 9, stored at -70°C, and diluted in HBSS immediately before use. Indomethacin (Sigma Chemical Co., St. Louis, Mo.), R020-5720 (d,1-6-chloro-amethyl-carbazole-2-acetic acid, kindly supplied by HoffmanLaRoche Co., Nutley, N. J.), 9,11-azoprosta-5,13-dienoic acid (Azo analogue 1, Upjohn Co.), and 8,11,14-eicosatrienoic acid (Nu-Chek Prep. Elysian, Minn.) were dissolved in 95% ethanol and diluted in HBSS. Ethanol at 0.1%, equivalent to its concentration in the reagents used in these studies, had no effect on LPS-induced increases in PMN adherence. Imidazole (Aldrich Chemical Co. Inc., Milwaukee, Wis.) and 1-benzylimidazole (Aldrich Chemical Co.) were dissolved in HBSS. Arachidonic acid (Sigma Chemical Co.) was purified by chromatography on silicic acid columns as described by Flower et al. (18) and stored in hexane at -35°C. Before use the hexane was evaporated, and the arachidonic acid was resuspended in 0.2% Na2CO3 and diluted to final concentration with HBSS. LPS (E. coli 026:B6, Difco Laboratories, Detroit, Mich.) was dissolved in HBSS and stored at -70°C until use. Thrombin (Sigma Chemical Co.) was dissolved in HBSS at appropriate concentrations and stored at -70°C.
One of the rabbit anti-TxB2 antibodies used in our experiments was prepared in our laboratory by immunization of a rabbit with TxB2 coupled to keyhole limpet hemocyanin. Antisera to TxB2 were also generously provided by Dr. W. Campbell, Dallas, Tex. and Dr. Carlo Patrono, Rome, Italy. These three antibodies show <0.3% crossreactivity with all tested prostanoids.
PMN and platelet preparation. Venous blood from healthy volunteers was obtained using sterile heparinized syringes, and PMN were separated by successive Ficoll-Hypaque (Pharmacia Fine Chemicals, Div. of Pharmacia Inc., Piscataway, N. J.) and dextran (Sigma Chemical Co.) gradient sedimentations (7). Erythrocytes were removed by hypotonic lysis, and the PMN (98+2% purity) were resuspended in HBSS at concentrations of 107/ml until use. Platelet concentrations in PMN preparations were generally three to five platelets per PMN and were reduced, in selected experiments, by low-speed (200 g) centrifugation of the PMN during all washing procedures, to a ratio of one platelet per PMN. Platelet-rich plasma was prepared by collecting blood into acid-citrate-dextrose anticoagulant. Blood was centrifuged at 1,200 g for 3 min and the supemate, containing platelet-rich plasma, was removed and centrifuged at 3,000 g for 6 min to concentrate the platelets. The pellet was resuspended in a small volume of platelet-poor plasma and recentrifuged at 180 g for 3 min to sediment remaining erythrocytes and leukocytes. The platelets were then diluted to 2 x 107/ml in HBSS before use. The leukocyte contamination of platelet preparations was <5 x 104/ml. PMN nylon adherence assay. Nylon adherence was modified from the method of MacGregor et al. (19) . PMN at 3.0 x 106/ml in HBSS were preincubated for 10 min at 37°C with or without cyclo-oxygenase inhibitors. Appropriate agents plus autologous plasma (to a final concentration of 10%)
were added to the cell suspension, which was rotated at 37°C for 1 h. 0.9-ml aliquots of the cell suspension were allowed to filter by gravity through Pasteur pipettes containing 30 Prostaglandin assay. PGE2, PGF2a, and TxB2 concentrations were determined by radioimmunoassay. Antisera to PGE2 and TxB2 were obtained from Pasteur Institute, Paris, France. Their characteristics have been described elsewhere (21, 22) . Anti-PGE2 cross-reacts with PGE1 by 2.7%. All other PG and their metabolites cross-react by <0.1% (21) . AntiTxB2 cross-reacts by <0 .1% with all PG tested (22) . Antiserum to PGF2a was produced in our laboratory and had the following characteristics: 50% inhibition of [3H]PGF2a binding occurred with 20-40 pg PGF2a. PGF,a, PGE1, PGE2, 6-oxo-PGF,a, 15-keto-PGF2a, and 13,14-dihydro-1i-ketoPGF2a cross-reacted by 63, 0.22, 0.13, 0.17, 0.27, and 0.33%, respectively. Thus, this antiserum did not distinguish PGF2a from PGF,a. PGB2, 15-keto-PGE2, and 13,14-dihydro-1S-keto-PGE2 cross-reacted by <0.01%.
RESULTS
First, we examined the effect of the cyclo-oxygenase inhibitors on the increase in PMN adherence to nylon induced by LPS in the presence of plasma (Table I) . The concentrations of inhibitors were selected on the basis of relative efficacy of inhibition in studies of bovine seminal vesicles (18) and human platelets (23) . Indomethacin, 1.0 ,ug/ml (3.5 ,uM), inhibited LPSaugmented PMN adherence by 74%. R020-5720 at concentrations up to 10.0 ,ug/ml (36 ,uM) produced significantly less inhibition than 1 ,ug/ml indomethacin, P < 0.05. Next we evaluated the effect of delayed addition of indomethacin on PMN adherence. The addition of indomethacin 10 min after LPS, rather than 10 min before, produced significantly less inhibition of adherence (mean of44% as compared to 60%, P < 0.01, Thromboxane A2 Enhances Polymorphonuclear Leukocyte Adhesiveness data not shown). Thus, indomethacin interfered predominantly with the initial effects of LPS on PMN, rather than reversing already established increases in adherence.
The suppression of LPS-stimulated nylon adherence by preincubation of PMN with cyclo-oxygenase inhibitors suggested that arachidonic acid metabolites resultant from fatty acid cyclo-oxygenase activity might mediate changes in PMN adherence. Accordingly, we studied the effect of arachidonic acid on PMN adherence ( Fig. 1 ). Arachidonic acid, at concentrations of 1.0-10 ,ug/ml, enhanced PMN adhesiveness to nylon severalfold. The enhancement of adhesiveness was diminished by 10 min preincubation of PMN with 1 or 10 ,guml indomethacin before addition of 10ug/ml arachidonic acid.
PGEl, PGE2, and PGF2a at concentrations of 0.1-3.0 ,ug/ml did not increase PMN adherence (Table II) .
Moreover, PGEj, PGE2, and PGF2a failed to enhance significantly the effects of 5 ,ug/ml LPS. Neither PGE2 nor PGF2a at 0.3 ,ug/ml was effective in reversing the inhibition of adherence observed when PMN were preincubated with 10 ,ug/ml indomethacin and then exposed to LPS (data not shown). Finally, in five of six experiments, we were unable to detect PGE2 or PGF2a in supernates of PMN (3 x 106/ml) incubated with 5-20 i.g/ml LPS and 10% autologous plasma for 60 min. The radioimmunoassays of PGE2 and PGF2a are capable of detecting these PG at minimal concentrations of -30 pg/ml. In the remaining experiment, however, PGE2, 100 and 300 pg/ml, was detected in supernates 60 and 120 min after incubation of PMN with LPS, 5 ,ug/ml. These data suggested that LPS-mediated increases in adherence were due to an arachidonic acid product different from PGE2 or PGF2a. We therefore examined the role of an alternative pathway of arachidonic acid metabolism, the Tx synthetic pathway. In five separate experiments with each, the two Tx synthetase inhibitors imidazole and 1-benzylimidazole, at concentrations known to inhibit Tx synthetase in platelets (24, 25) and lymphocytes (26) , suppressed LPS-augmented adherence (Fig. 2) . Neither agent affected basal PMN 5 ,ug/ml LPS increased PMN adhesiveness to plastic >twofold (Table III) . PMN failed to aggregate on the surface of the plastic following exposure to LPS. 1 ,ug/ml indomethacin and 400 ,ug/ml imidazole significantly inhibited LPSstimulated adherence of PMN to plastic by 44 and 59%, respectively.
PGI2 inhibits platelet aggregation induced by a variety of physiologic and pharmacologic agents (28) . This effect is thought to be mediated by increases of intracellular cyclic AMP concentrations. Since cyclic AMP has also been proposed to be a potential regulator of PMN function, including adherence and aggregation, we hypothesized that PGI2 might be an inhibitor of LPS-stimulated PMN adherence. PGI2 at concentrations of 2.5 and 5.0 ng/ml inhibited LPS-induced aug- Next, we sought to determine whether a factor such as Tx was released by LPS-stimulated PMN and was capable of enhancing the adhesiveness of unstimulated PMN. We used parabiotic chambers separated by a low molecular weight cutoff cellulose membrane (3,500 daltons) that excluded substances having higher molecular weights such as C5a (1.12 x 101 daltons [29] ), which are generated by the interaction of LPS with plasma (30) , and LPS itself (>105 daltons [31] ). Incubation of PMN with 10% autologous plasma on both sides of the membrane resulted in basal nylon adherence of 6% (Table IV) . If 5),g/ml LPS was incubated with PMN on one side of the chamber, the nylon adherence of PMN in both compartments was enhanced significantly, despite exclusion of C5a and LPS by the membrane (2A, 2B). This finding was consistent with generation of a low molecular weight substance capable ofenhancing adhesion to nylon. This substance was labile, as suggested by experiments in which supernates of PMN exposed to LPS for 60 min were incubated at 370C for 5 min. When placed in one compartment of a chamber, the supernates were now incapable of enhancing the adherence of fresh PMN in the other compartment (4, 2BI).
Exposure of the PMN in chamber B to imidazole did not prevent the stimulation of adherence in these PMN in response to LPS addition to chamber A (4A, B). 5 ,ug/ml LPS and PMN were preincubated for 10 min before addition to compartment A. Simultaneously, 400,ug/ml imidazole and PMN were preincubated 10 min before addition to compartment B. Adherence of both stimulated and unstimulated PMN was increased. Furthermore, preincubation ofPMN in chamber A with 400 itg/ml imidazole for 10 min blocked the enhancement of adherence in both A and B chambers. Thus, imidazole suppressed the generation of a low molecular weight diffusible factor, but did not inhibit its adherence-augmenting activity. These data are consistent with the release of TxA2 by LPS-stimulated PMN, which can directly increase the adherence of unstimulated PMN. Using a radioimmunoassay for TxB2, a 10-fold increase in immunoreactive TxB2 was detected following exposure of PMN to LPS for 120 min (Fig. 4) . This increment was blocked by preincubation of PMN with 32 ,ug/ml 1-benzylimidazole, a concentration that nearly completely reversed LPS augmentation of PMN ad- In five experiments (mean±SEM) LPS-stimulated PMN produced significantly greater amounts of TxB2 at 60 and 120 min incubation than unstimulated PMN (P < 0.05, t test).
herence (Fig. 2) . The role of TxA2 as mediator of LPSstimulated PMN adherence was further evaluated using several rabbit antibodies against TxB2. Preincubation of PMN with a 1/100 and 1/200 dilution of anti-TxB2 plasma, prepared by us, significantly inhibited LPS enhancement of PMN adherence by 56 and 32%, respectively (data not shown). PMN adherence was not affected by the antibody alone nor by serum obtained from a rabbit immunized with tetanus toxoid. Two additional antibodies from different laboratories (see Methods) also significantly inhibited LPS-augmented PMN adherence by 50% (P < 0.002) and 75% (P < 0.005) at dilutions of 1/10,000 and 1/4,000, respectively. The inhibition of LPS-stimulated adherence presumably occurred by cross-reaction of TxA2 with anti-TxB2. This is supported by the observation that exogenous TxB2 (at concentrations of 100-500 pg/ml; data not shown) did not enhance PMN adherence.
The aforementioned experiments do not unambiguously identify the source of TxA2 because of the possibility of platelet release of TxA2 in response to LPS. Experiments using platelet preparations having PMN ratios of 10:1 and 1:1 showed similar enhancement of PMN adherence after exposure to 5 jig/ml LPS (data not shown), suggesting that PMN rather than platelet production ofTxA2 were responsible for the increase in adherence. To evaluate further the role of platelet TxA2, we incubated 2 x 107 platelets (equal to the maximal number of platelets present in our PMN preparations) on one side with purified PMN on the other side of parabiotic chambers (Table V) . Platelets alone or exposed to 5 u.g/ml LPS did not increase PMN adherence. Thrombin-stimulated platelets in chamber A 
In each series of experiments, 2 x 107 platelets in 10% heterologous normal plasma were added to the A side of parabiotic chambers separated by a low molecular mass cutoff membrane. Simultaneously, 3 x 106 PMN in 10% autologous plasma were added to the B side and PMN adherence to nylon was determined after 60 min incubation at 37°C on a shaking platform. * Differs from 1B, P < 0.0005, t test. t A supemate obtained from platelets exposed to thrombin for 60 min was incubated at 37°C for 5 min, then added to the compartment of a second chamber, and the adherence of fresh PMN in the B, compartment was determined after 60 min. § Anti-TxB2 antibody (final dilution 1/100) was preincubated with PMN for 10 min on B side of chamber before addition of platelets and thrombin to A side. 1 (32, 33) to stimulate aggregation and platelet degranulation coincident with its metabolism to various bioactive endproducts. Our studies demonstrate that arachidonic acid increases PMN adherence, an effect that can be blocked by cyclo-oxygenase and Tx synthetase inhibitors. Furthermore, the lack of effect of 8,11,14-eicosatrienoic acid, which is converted hy the platelet to PGH, and ultimately to monoenoic PG but not TxA, (27) (41, 42) . Enhanced adhesiveness to nylon in our system persisted to 60 min and, in the instance of arachidonic acid stimulation, increased at 120 min. However, occasional cellular aggregates were present in incubation mixtures after 60 min. Using an assay of PMN adhesion to plastic surfaces, we were able to monitor aggregation microscopically; LPS did not cause significant aggregation of PMN but increased their adhesion to plastic, an effect that was inhibited by both indomethacin and imidazole. Our data cannot exclude conclusively an effect ofaggregated PMN on the adherence assay, but the assay of PMN adhesiveness to plastic confirmed the observations obtained with the nylon adherence assay, i.e., a primary augmentation of adherence.
PGI2 also inhibited LPS-induced PMN adherence. 
